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ECOMBINANT DNA EXPERIMENTATION has been

~with us for more than a decade, embattled since its inception.
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Scientists have been questioned and have questioned themselves about
the safety and advisability of their experiments. The public has been
bombarded on the one hand by scare headlines suggesting that scientists are making dangerous organisms or might well make them by
accident and on the other by hype promising such genetic engineering
wonders as plants that pump gas directly into one's automobile. Not
surprisingly, there are neither monsters nor miracles in the reality of
genetic engineering. Yet the real story, the real history of this particular
scientific development, is both fascinating and deeply puzzling. It is
indeed the story of a substantial scientific breakthrough, one whose
impact on basic biological knowledge has already been profound and
whose future can only be glimpsed. But it is much more than that. It
is the story of the first concerted effort by scientists to foresee and
forestall the possibility of harm, however inadvertent. It is the history
of that extraordinarily well-intentioned effort somehow gone sour, the
public unsure what to believe and scientists sure only that the controversy became unbelievable. It is a contemporary cautionary tale of
science and public policy, of scientists and bureaucrats and crusaders.
It is about the process of defining a new kind of dialogue between
science and society and the attendant difficulties and near derailments.
This essay evolved out of a lecture I gave as a Phi Beta Kappa Visiting Scholar during the 1984-85 academic year, when recombinant
DNA, after several years' adumbration, again hit the headlines. In
reworking it for publication, I have tried to preserve its several original
objectives. The first of these was to communicate some sense of what
recombinant DNA technology is about scientifically, where it comes
from historically and where it might realistically lead us in the future.
My second objective was to recount briefly the history of the
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recombinant DNA controversy, beginning with the concerns expressed
by scientists more than a decade ago about the potential hazards of
recombining DNA molecules and ending with the current debate over
gene transfer and release into the environment of genetically engineered organisms. My third objective was to gain some perspective
on the situation and to include students in my own continuing struggles to distinguish the real from the specious issues and critics and to
make public policy wisely in acknowledged ignorance. I have omitted
my original detailed description of recombinant DNA techniques, not
because I thought it unimportant, but because of John Vournakis's
excellent essay on the subject in a previous issue of the Scholar. 1

r. John N. Vournakis, "Genetic

Engineering and Recombinant DNA,"
Syracuse Scholar 5 (Fall 1984) : 57-65.

IS A POPULAR MISCONCEPTION that recombinant
DNA technology is about cloning organisms: plants, animals, and
even people. It isn't. It is about cloning genes, bits of DNA. Perhaps
an analogy will make the difference more meaningful. An automobile
is a rather complex machine assembled from many simple parts, some
as simple as a screw. For each part, even each screw, there exists a plan,
a set of specifications. If one were to obtain and make a million copies
of the specifications on a copying machine, one would have done
something quite analogous to what the recombinant DNA technician
or gene cloner does. The million sheets of paper cannot be confused
with a million cars. The many copies of a gene generated through
recombinant DNA technology stand in precisely the same relation to
the organism from which the gene was isolated as does the stack of
paper to the car. Indeed the analogy is quite apt because a gene is
basically a set of instructions. Genes contain in coded form the instructions for assembling another molecule, usually a protein. Proteins are big molecules; we call them macromolecules. Proteins make
up much of the structure and substance of all living organisms. They
also do the work that goes on in an organism: extracting energy from
food and converting it to usable form, moving, and growing. Genes
are blueprints; they are the instructions for making a tree or a
butterfly. Genes are what heredity is all about; they are its elementary
units. Genes are what we pass to our offspring to make them irritatingly and endearingly like us.
We know that heredity has fascinated human beings throughout
recorded history and the fascination undoubtedly began before that.
Humans had an intuitive grasp of heredity and genetics long before
they knew what genes were, and they used that knowledge to carry
out what we now give the rather sinister designation "genetic manipulation." ll:aditional genetic manipulation is called breeding. Humans
have bred and continue to breed plants and animals for a variety of
purposes, ranging from increased food value at the practical end of the
spectrum to aesthetic pleasure at the artistic end. Breeding is the
mating or genetic crossing of individuals with desirable characteristics
to obtain new or better combinations of traits in the offspring. Breeding isn't a very efficient process, since it involves discarding most of the
progeny, selecting just a few for further propagation. But selective
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breeding can be (and was) done with no knowledge of genes or genetics, and it is an extremely effective method of genetic manipulation.
Indeed, one of the arguments that Charles Darwin used to support his
hypothesis of natural selection as a major force in the long-term biological change that he called evolution was the extraordinary
effectiveness of the artificial selection techniques used by human beings in the breeding of plants and animals.
The point of all this is that the practice of genetic manipulation, of
creating and propagating new combinations of genes, is a very old one
in human culture. What is new is that we have learned enough to do it
less haphazardly than traditional methods allow. We are now able to
isolate and move a single gene at a time. We can also move genes
between very different organisms, with the potential of eliminating
barriers that have long frustrated the breeder. Our present genetic
capabilities are very much a product of this century, but the extraordinary growth in our genetic knowledge began almost half a century
earlier with the experiments of the monk Gregor Mendel on peas. The
results of his experiments were published in 1865 but received essentially no attention until the turn of the century, when his work was
discovered and appreciated by several European botanists. In describing Mendel's experiments in 1902, the biologist William Bateson
wrote, "An exact determination of the laws of heredity will probably
work more change in man's outlook on the world, and in his power
over nature, than any other advance in natural knowledge that can be
foreseen." 2
Although one must acknowledge a few influential advances that
were not foreseen, Bateson's statement remains remarkably prescient.
Mendel's work, or perhaps the rediscovery of his work, clearly marks
the beginning of this century's explosion of genetic knowledge . The
first decades of the century saw the confirmation, consolidation, and
generalization of what came to be called Mendel's laws, rules that
describe the hereditary behavior of genes. Genes were defined as the
units of heredity and, as more and more genes were identified, it
became evident that they could be arranged in sets of linear arrays that
acted as units . In time, we learned that the linear arrays corresponded
to structures in the nucleus: the chromosomes, the physical bearers of
genes. During the 1940s and 1950s, the chemical nature of the genetic
material was identified as deoxyribonucleic acid (DNA), and the DNA
molecule was understood to be a long, helical polymer comprising
two complementary strands, the familiar double helix. The structure
of DNA, worked on by many but worked out by James Watson and
Francis Crick, had substantial explanatory power for heredity. Inherent in the chemical structure was the explanation for hereditary constancy. Each strand of the double helix acts as a template for the
assembly of a complementary strand, resulting in the creation of two
daughter DNA helices having the same structure and information as
the parent DNA molecule.
Genetics and biochemistry came together in an enormously productive way during the 1950s and 1960s to provide an understanding of
how information is stored in the DNA molecule and how DNA is
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replicated. We learned how information is encoded in the linear sequence of the four different structural subunits in DNA, the nucleotides. We learned, too, how the cell decoded the information to convert it to protein structure and to the structure of ribonucleic acid, the
cell's other informational nucleic acid. We understood how the hereditary material, the DNA, is replicated. We learned that there are proteins, called enzymes, which made the nucleotide subunits. There are
enzymes that polymerize or link together the nucleotides on the appropriate DNA template and others that repair the mistakes the first
ones make. All in all, we came to appreciate the exquisite fidelity with
which the hereditary molecule is replicated, a fidelity inherent in Mendel's laws. But we also learned that change or mutation is inherent in
the chemistry of the nucleotides and the replication mechanism, providing a molecular explanation for the origin of the differences
between organisms that Darwin believed to be central to biological
evolution.

A

S' OUR KNOWLEDGE OF HOW DNA IS USED,

""\ replicated, and otherwise processed in the cells grew, so did our
ability to manipulate DNA in the laboratory. One fact that emerged
during this period that proved seminal for the development of our
present recombinant DNA technology was that certain bacteria have
the ability to tell the difference between their own hereditary material
and DNA from other organisms. What they have are certain enzymes,
called restriction endonucleases, that can cut the DNA very precisely
at special sequences in such a way that the cut ends are, in effect,
"sticky." The stickiness results because the restriction enzymes cut the
two strands of the DNA molecule at slightly different places, leaving
protruding single-stranded ends. The overhanging single-stranded
ends of two molecules are held together by the chemical forces that
keep the complementary strands of the DNA double helix together.
The reason that these enzymes allow the bacterial cell to distinguish its
own DNA from foreign DNA is that the bacterial cell has another
enzyme that covers, but only in its own DNA, the target sequence
that the enzyme cuts. The bacterial enzyme can therefore destroy
invading DNA, but not its own. This odd little bacterial defense tactic
provided one of the essential elements for the development of contemporary recombinant DNA technology, because DNAs from very
different sources can be cut with the same restriction enzyme and put
together or "recombined" via their sticky ends. The recombined or
recombinant DNA molecules can then be ligatedor sealed together
permanently by another DNA-processing enzyme, appropriately
called a ligase. 3
Another important discovery that contributed to the development
of recombinant DNA technology was that the bacterial chromosome
isn't the only DNA molecule in a bacterial cell. Bacteria have, in
addition to their chromosome, tiny circular DNA molecules called
plasmids. Plasmids generally outreplicate the bacterial chromosome.
Moreover, they can sustain genetic changes or mutations that allow
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them to exist in very large numbers in the bacterial cell. The ability of
plasmids to replicate themselves many times over provides the means
of cloning recombinant DNA molecules. If a plasmid is cut with a
restriction enzyme, recombined and ligated with DNA from another
source (be it elephant or butterfly), and returned to the bacterium, the
bacterium and its progeny will copy and recopy the recombinant
DNA molecule millions of times, much like the copying machine I
used in my analogy. The copying is the cloning, for it produces millions of identical copies of the DNA that was originally inserted into
the plasmid. This is important to the molecular biologist because one
simply cannot see or study a single molecule of anything. Imagine
studying the properties of water (or even quenching your thirst) if you
had only one molecule of it. A glassful of water contains a million
times a billion times a billion molecules of water. Recombinant DNA
technology lets the molecular biologist turn a single recombinant
DNA molecule into a teaspoonful of DNA. And with even a teaspoonful of a pure gene, the resourceful molecular biologist can begin
to quench his or her thirst to know how a gene is put together and
how it works.
Why, then, is recombinant DNA technology so terrific or terrifYing, depending on your perspective? First, it is important to appreciate that processes very similar to those I have just described occur
naturally. There are plasmids that can insert themselves into the bacterial chromosome and come out again, having picked up a bacterial
gene or two. There are also transposable genes, genes that can jump
from one chromosome to another. And most plasmids (although not
those used for cloning) have a naturally evolved system for traveling
from bacterium to bacterium. Thus there are natural mechanisms for
cloning genes, many of which were exploited by bacterial geneticists
long before the development of recombinant DNA techniques. The
reason that recombinant DNA techniques are so important is simply
that they make it possible for us to reach a completely new level in our
understanding of how complex organisms function. Before the development of these techniques, we had achieved a reasonably good understanding of the basic biochemical principles at work in all organisms. This had been accomplished largely through the use of very
simple model organisms or bacterial systems in which one could use
natural gene cloning mechanisms to isolate a gene of interest. But the
genes of complex higher organisms, the very organisms we wanted
most to know about, were not accessible to study by available techniques. We were rather in the position of a student on the steps of a
locked library. He might know quite well what books are made of, the
language in which they are written and how they are filed on the
shelves, but unless he can get into the library, withdraw a book or two,
and begin to read, he will never understand the information content
of the library. And that is just where we were in our study of genes in
higher organisms. We knew what genes were made of, how information was generally stored in them, and even a good deal about where
they were located on the chromosomes. But recombinant DNA techniques made it possible to isolate and study one gene at a time.
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WILL USE A COUPLE OF EXAMPLES to illustrate what
II these
techniques have already allowed us to learn and what they will
enable us to do in the foreseeable future.
Before these techniques were developed, we knew that higher organisms had genes that contained the information for making hemoglobin, the red blood cell protein that carries oxygen from the lungs to
the cells in all the parts of the body. Hemoglobin genes have now been
cloned both from normal individuals and from individuals with a
variety of diseases affecting the hemoglobin. These include the familiar
and deadly sickle-cell anemias and thalassemias. What has emerged is
that the genes themselves are defective in these diseases. The amount
ofgene damage can be small or quite large: an abnormal gene can differ
from a normal one by just a single nucleotide or it can have a large gap,
termed a deletion, in it. Some patients are even missing entire hemoglobin genes. Scientists are currently developing methods that should
make it possible to transplant cloned normal hemoglobin genes into
patients with defective genes, just as we can now give blood transfusions, transplant internal organs, or treat people with insulin. There
are other examples, perhaps a bit less dramatic, of the medical utility of
recombinant DNA technology. These include the large-scale production of human insulin from cloned genes and of human growth hormone. Recombinant DNA technology has facilitated and made safer
the development of vaccines for a number of human and animal diseases, including hepatitis virus and hoof-and-mouth disease . Recombinant DNA techniques have proved important in vaccine development because they allow the scientist to work with just part of the
viral genes at a time. He or she no longer has to work with the entire,
sometimes highly lethal or debilitating virus.
Another example of the power of recombinant DNA techniques
comes from my own work on the transposable elements of corn
plants. I have already mentioned the existence of jumping genes in
bacteria. Their proper name is transposable elements and they are
numerous and widespread in nature. They weren't even discovered in
bacteria but in maize plants, about forty years ago, by Barbara McClintock. McClintock, a classical geneticist, identified transposable
elements as genes that did rather odd things. Unlike most genes, they
did not always have a fixed chromosomal location but could occasionally pick up and move to a new place. Until they were isolated in
my laboratory three years ago with the aid of recombinant DNA
techniques, McClintock's transposable elements were just a genetic
abstraction. We now have cloned copies of several of the elements and
have analyzed their structure in great detail. We can now go on to the
next step of putting them to work.
What kind of work might transposable elements be able to do?
l:ransposable elements not only move around themselves but also
move other genes around. We have so far relied solely on breeding and
selection to move genes around in plants. Although these procedures
have been very successful, they are limited. To begin with, it takes a
long time, perhaps ten years, to develop a new crop strain, for example, that has good growth and yield characteristics, as well as a new
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gene for disease resistance. Moreover, conventional breeding techniques are restricted to plants that will crossbreed. All organisms,
including plants, will breed only with very closely related organisms. A
cabbage and a cactus, for example, can grow side by side without
making a cabbage-cactus hybrid because they are sexually incompatible. Yet these plants have a great deal in common at a fundamental
genetic level. To use my book analogy again, each of these plants is like
a different book. The words in the book may well be in the same
language and one might even find a few identical sentences in both
books, yet the information contained in each is clearly different.
Nonetheless, it might also be that a sentence from one book, judiciously introduced, might enrich the other. And so it is with crop
plants. If we could keep all of the information painstakingly assembled
by the plant breeder in our extraordinary hybrid corn, but introduce
an extra gene that confers resistance to a debilitating viral disease, it
would be of enormous value. With the isolation of transposable elements, we have the means of moving such genes around. What we do
not yet have, but should have soon, are genes that confer disease
resistance. Thus recombinant DNA techniques should eventually allow us to enhance the plant breeder's work by the specific introduction of desirable single genes from a variety of sources.

l

4. Paul Berget al.,

Science 185 (1974) :
303.
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F I HAVE CONVEYED THE NOTION that the history of
recombinant DNA experimentation is an untroubled scientific success story, I have not misrepresented the situation substantially. And
yet we have been hearing about the potential hazards of recombinant
DNA research for a decade. No reasonably well-informed individual in
our society has escaped reading or hearing at least one account of the
monsters that biotechnology might well bring, deliberately or by accident. What are the real dangers? Are serious scientists concerned or is
this the stuff of science fiction?
These are questions not easily answered. Indeed, concern over
potential hazards of certain recombinant DNA experiments began
among scientists-not a fringe group with little knowledge of the
subject but the very scientists centrally involved in the early stages of
developing the techniques. This concern crystallized in an open letter
to the scientific community, "Potential Biohazards of Recombinant
DNA Molecules," published in Science in 1974. The letter was signed
by eleven eminent molecular biologists, among them several Nobel
laureates including James Watson, codiscoverer of the structure of
DNA. The crux of the letter is contained in three sentences: "Several
groups of scientists are now planning to use this technology to create
recombinant DNA's from a variety of ... viral, animal, and bacterial
sources. Although such experiments are likely to facilitate the solution
of important theoretical and practical biological problems, they would
also result in the creation of novel types of infectious DNA elements
whose biological properties cannot be completely predicted in advance. There is serious concern that some of these artificial recombinant DNA molecules could prove biologically hazardous." 4
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The authors of the letter went on to make some specific recommendations. First, they suggested that certain kinds of experiments,
which they felt at the time to have the greatest chance of being hazardous, not be done for the moment. Second, they recommended
that scientists themselves organize a meeting to discuss the potential
hazards of the experiments. And third, they requested that the director of the National Institutes of Health (NIH) establish an advisory
committee to oversee "an experimental program to evaluate the potential biological and ecological hazards of (certain kinds) of recombinant DNA molecules," develop procedures to minimize the
spread of such molecules, and devise guidelines for investigators working with "potentially hazardous recombinant DNA molecules."
The suggestions of the letter-writing Berg Committee, as it came to
be called after its chairman Paul Berg, were all implemented. An international conference was convened, the famous, contentious Asilomar
conference, out of which emerged the first guidelines for experiments
involving recombinant DNA and a call for a moratorium on certain
kinds of experiments. The NIH also responded and established the
Recombinant DNA Advisory Committee to elaborate the guidelines
and to formulate studies assessing risk. The difficulty of the undertaking soon became apparent. Since the risks of recombinant DNA
research were hypothetical, the guidelines could be based only on
people's guesses about dangers. Scientists spent a considerable amount
of time thinking up scenarios. With known hazards, such as radiation,
this is a sensible procedure; one can calculate from the known effects
of radiation on human beings the consequences of a radiation spill of a
certain magnitude. But this cannot be done with hypothetical hazards
for the simple reason that they are hypothetical. Lacking basic data,
one tends to imagine the worst. So the guidelines for recombinant
DNA research acquired an awesome aspect. They were written as if
organisms with introduced genes were in fact quite dangerous. They
specified that the work had to be done in special laboratories and had
to employ debilitated organisms that had no chance of surviving in
nature, even if someone were inadvertently to liberate the organisms
in large quantities.
Although the necessity for new and stringent regulations was a
matter of some contention among scientists from the beginning, what
no one really foresaw was the intense, troubling, and debilitating
public debate that arose over recombinant DNA. Since hindsight has a
certain clarity that foresight lacks, one can see that what happened
was, in some measure, predictable. If some of the best minds working
on DNA say they are worried about the potential hazards of recombinant DNA, it is difficult to escape the suspicion that there really
is something to worry about. What responsible public-policy maker
would fail to heed the concerns the scientists themselves expressed?
Who would not be in favor of the strictest regulations imaginable?
Worse yet, if five years later the very same scientists said there was no
hazard, who would not begin to wonder whether his or her faith in
the knowledge and judgment of scientists was a bit misplaced?
Unfortunately, the fact that scientists of stature issued the first
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words of caution lent support to the perception of imminent danger.
The very existence and stringency of the guidelines came to imply that
the experiments were unsafe. Amplified by a good deal of attention
from the communications media, the recombinant DNA controversy
reached everyone. The distinction between real, quantifiable hazards
and potential hazards blurred and disappeared; people were quite
apprehensive. Yet as the years passed, the accumulation of basic
knowledge and experience with recombinant DNA, taken together
with the results of risk-assessment studies, provided more and more
evidence that recombinant DNA experiments were not inherently
hazardous. Indeed, it is a bit ironic that some of the experiments
originally thought to be the most hazardous turned out to be substantial improvements on the safety of methods used before recombinant
DNA techniques were developed. This is because our most feared
disease organisms evolved with us. Their ability to cause disease depends on their knowledge of us, if I can be forgiven the anthropomorphism. Thus for example a toxin-producing bacterium can generally be a pathogen only if it knows how to deliver its toxin to the
right place. For a bacterium that lives in the gut, this can mean the
ability to attach to and proliferate in the area that the toxin affects.
Cloning the toxin gene into a laboratory bacterial strain does not turn
the laboratory bacterium into a pathogen. The laboratory strain cannot survive in the gut, much less proliferate and deliver the toxin to
the appropriate target cells. So the safest way to analyze toxin genes is
in fact to clone them in laboratory bacterial strains.

CONTROVERSY OVER THE SAFETY of recombil1~E
~:Ut DNA has subsided, but only to some extent. It is now
generally agreed that the initial guidelines for recombinant DNA research were unnecessarily stringent and that much more time and
money were expended on the construction and equipping of special
facilities and the construction of special "safe" organisms than the real
dangers justified. Early in their development, the guidelines were
cumbersome and the administrative work of complying with them
was excessive. Research was delayed in many cases, although the delays
seemed much more burdensome while endured than they appear in
retrospect. There were efforts to convert the guidelines into regulations through legislation at the national level, but by good fortune
and the efforts of several prominent biologists, such efforts failed. And
the NIH Recombinant DNA Advisory Committee proved itself able
to absorb accumulating information, gradually relaxing the guidelines
as the results of risk-assessment studies became available. An unfortunate consequence of the controversy is that its intensity and
abrasiveness obscured and distorted the legitimate, responsible concerns of the original group of scientists. Many admit that they would
not speak out again under similar circumstances. It is indeed unfortunate that this first effort to foresee harmful outcomes of wellintentioned experiments became so embattled. What we have understood from this experience is the difficulty for us as an open society of
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developing effective ways of venturing cautiously into the unknown,
neither minimizing nor exaggerating the dangers, neither immobilizing ourselves with restrictive regulations nor proceeding without
care. And the task is far from done; indeed, current applications of
recombinant DNA research are again in the news, again under fire .
Recombinant DNA techniques have begun to come of age. We are
witnessing the emergence of the first efforts to put the results of the
knowledge gained through these techniques to work in both medicine
and agriculture. Such practical applications raise issues that have not
previously been considered. The applications now under discussion
involve the introduction of genetically engineered organisms into the
environment and efforts to transfer cloned genes between species to
improve the value of agriculturally important animals. During the past
year or two, much of the Recombinant DNA Advisory Committee's
effort, as well as that of similar committees that have been formed in
other government agencies such as the Environmental Protection
Agency and the Department of Agriculture, has gone into the difficult
task of divising suitable ways of assessing the chance that a genetically
altered organism will have unexpected properties when released into
the environment. I believe that the various committees have been and
will be effective in this role. The open, prior discussion of new types of
technological developments is useful. In some sense, it is what the
original signers of the Berg letter had in mind, a concerted, ongoing
effort to think through in advance the safest way to do a new type of
experiment. But this view is far from universal and once again we find
ourselves in the midst of public controversy over potential hazards,
unable to agree on a prudent course. Some would forbid all medical
and agricultural applications as too risky, whereas others believe that
the risks are negligible.
The imminence of concrete applications in both agriculture and
medicine has also prompted discussion of their ethical implications.
Some view the possible applications of recombinant DNA techniques
as so novel that they confront us with unprecedented ethical decisions
and moral choices. It is the ability to control our genetic destiny, as
well as that of other organisms, that is regarded as disquietingly new,
but I think that this is perhaps because we forget how much genetic
manipulation we already do. And perhaps, too, because we do not
stop to consider the extent to which organisms, all organisms, influence each other genetically, altering each other's evolutionary fates.

DOMESTICATION OF PLANTS AND ANIMALS
lI~E
;~volved profound genetic changes; it was an evolutionary process. The plants and animals that evolved with us are very different
from their wild ancestors. Corn provides a dramatic example of the
rapidity with which a plant can evolve under the influence of another
organism, in this case Homo sapiens. Today's familiar corn plant is very
different from its closest living wild relative, the teosinte plant. Teosinte is a grass; it has narrow leaves, grows in clumps, and produces
seed in the way other grasses do. Our modern corn plant has a single
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robust stalk and carries its many hundreds of seeds, the corn kernels,
on bulky ears that grow out of the stalk halfway up the plant. Yet these
plants are so closely related that they form fertile hybrids. Furthermore, certain DNA sequences in their chromosomes are sufficiently
similar that we estimate that the two species diverged only about
w,ooo years ago, when human beings first appeared in their habitat.
In that short span of time, the plant has changed genetically from just
another wild grass to one of the most productive food plants in existence. Let me give you some idea of how short an evolutionary time
span this is. We know from paleobotanical evidence that ferns have
looked much like they do today for so to wo million years. A million
and a half years ago, our predecessor Homo erectus wandered the earth.
Neanderthal man, a subspecies of our own species Home sapiens, dates
back about ISo,ooo years. Corn evolved in an evolutionary instant.
How did this happen? We can't go back w,ooo years and know
exactly, of course, but we can make some good guesses based on what
we have accomplished in plant breeding in the past few centuries.
Contemporary breeding involves making controlled crosses between
individuals with desirable characteristics and then selecting the best
progeny for further propagation. Our ancestors undoubtedly began
their breeding efforts simply by selecting certain offspring of plants and
animals and discarding others. This is selective propagation, and it
works because it automatically restricts the mating population to the
selected individuals. Why do these procedures make organisms change
or evolve? They don't, really. All they do is select for further reproduction those organisms that already have important genetic
changes. The genetic material, the genes of all organisms, is in a
constant state of flux. The more we learn about genes at the molecular
level, the more we appreciate the extent to which chromosomes and
genes are continuously changing in both their structure and their
relationships to each other. This genetic instability is the everrenewable source of future change, of new directions in the evolution
of organisms. The breeder culls, picking certain directions of change
over others. The selection process works because it is the nature of
living organisms to change. Our objectives are, of course, to select out
those plants or animals whose characteristics best suit us. Corn is one
of our most dramatic success stories. We suspect that corn is almost
entirely the product of human intervention.
Human beings and their corn plants are interdependent. We depend on corn for food and it depends on us for survival. The corn
plant cannot survive without human beings because its seeds, the
kernels, are so firmly attached to the ears that they do not fall off. In
technical terms, the plant has no natural dispersal mechanism. Human beings serve the corn plant by removing the kernels from the ears
and dispersing them to farmers, who in turn plant and tend the corn,
ensuring its survival. Such mutual interdependence of organisms is by
no means a human invention. It is evident everywhere in the living
world. For example, many plants are completely dependent on insects
for pollination, the step in the reproductive cycle that initiates the
development of the seeds that grow into the next generation of plants.
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Such mutual interdependence develops over a long period of time. We
have come to call the process coevolution. Coevolved organisms are
often so interdependent that the extinction of one organism assures
the extinction of another. In one of his natural history essays, Steven J.
Gould tells the poignant story of a coevolved pair of organisms, one of
which became extinct, leaving the other behind to live out an uncomfortable existence. While wandering on the beach in Bermuda as a
student, Gould noticed some hermit crabs that seemed, for the most
part, to be living in uncomfortably small snail shells. Just a few of
them had shells of a suitable size. All of the larger, more commodious
shells, what few there were of them, turned out to be fossil shells. It
appears that the snail species that this particular hermit crab coevolved
with had become extinct, leaving only small-shelled snails. The poor
hermit crab was condemned to cramped quarters for the rest of its
existence. Only a few of the crabs, those lucky enough to find a fossil
snail shell, would ever have a comfortable house. And in our contemporary jargon, the fossil shells are surely a nonrenewable resource. 5

~ J\\ Y OBJECTIVE IN ALL OF THIS is to illustrate two

5. See Stephen J. Gould, "Nature's
Odd Couples," The Panda's Thumb
(New York: Norton, 1980), pp. 278-88.

V \\

important points. The first is that change is fundamental to
living organisms. The second is that organisms are intimately interconnected and participate in each others' evolution. Life is our planet's ever-changing, ongoing experiment in which success is never a sure
thing (a hermit crab cannot even count on a decent housing subsidy).
We human beings participate in interdependent relationships, just as
do other species. We, like other organisms, exert our influence on the
evolution of plants and other animals and are in turn influenced.
Although recombinant DNA techniques extend our ability to
influence our biological environment, the exercise of such influence is
by no means novel. Our success in breeding plants and animals has
improved in the past few centuries as we have gradually come to
understand more and more about heredity and genetics, but we have
been in the breeding business, the business of genetic manipulation,
for a few thousand years.
Nonetheless, in certain respects recombinant DNA technology has
dramatically extended our ability to influence our biological environment. It allows us to transfer genes between very different organisms,
not only to learn how the genes work but to develop genetic systems
to do specific tasks. We have already put the humble bacterium E. coli
to work making products of medical value, such as growth hormone,
interferon, and insulin. There is much work yet to be done for which
recombinant DNA techniques should be ideally suited. We can begin
to look forward to a time when we will be able to reach across the
genetic barriers that have hitherto stopped breeders to introduce genes
from diverse sources that will enhance the growth rate or food value of
both plants and animals. Of particular importance is the possibility
that we will be able to introduce genes to do some of the things we
now do with fertilizers, herbicides, and pesticides.
Although I have argued that recombinant DNA techniques are
J
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continuous with previous genetic technologies, I do not mean to
imply that the application of recombinant DNA technology in agriculture and medicine will be without ethical dilemmas. It is simply
that the kinds of ethical questions we are likely to confront are ones we
are already grappling with. As with any human technology, there
exists the possibility of misuse. We are, as a society, committed to the
beneficial applications of technology. We struggle to keep our commitment, difficult though that struggle might seem on occasion. There is
nothing about recombinant DNA technology that calls that commitment into question. In medicine, our overall goal is to ameliorate
suffering and cure disease. Gene therapy is just another of many recent
developments, not unlike organ transplantation and sophisticated
drug therapies. It holds the promise of eradicating some hereditary
diseases forever. This has been viewed as quite novel, but it is not, I
think, altogether different from our ability to eradicate smallpox. In
that case we eliminated an organism by eliminating ourselves as its
host; by gene therapy we might be able to eliminate a gene defect. I
can foresee that gene therapy will confront us with choices. I can
anticipate that gene therapy, like other medical treatments, will not be
invariably successful. The decision to resort to such therapy may well
be a difficult one. But that is not different from many of the difficult
choices that modern medicine confronts us with today. We must continue to seek to balance the chances of cure against the chances of
failure and more suffering. What I believe is most important to appreciate is that, although recombinant DNA technology extends our
ability to shape ourselves and our biological environment, we already
do so extensively, if not always wisely.
What I do find both extraordinary and deeply disquieting is the
emergence of a concerted campaign to prevent research leading to
practical applications of recombinant DNA in agriculture and medicine. This is essentially the personal crusade of one individual, Jeremy
Rifkin, who believes that there is something intrinsically immoral
about research involving recombinant DNA and gene transfer. And he
is attempting to impose his conviction on scientists, on universities,
on the government, and on industrial concerns. Through a variety of
legal maneuvers, he has slowed or stopped field testing of agriculturally useful organisms developed with recombinant DNA techniques. He further requested that the Recombinant DNA Advisory
Committee amend the guidelines governing recombinant DNA research not only to prohibit but to declare immoral and unethical all
transfer of genetic traits between mammalian species and from any
mammalian species into humans. Rifkin believes that the transfer of a
single gene represents "a fundamental assault on the principle of species integrity." He would have had the committee condemn such
experimentation as "a gross and unconscionable violation of our telos
as a species." He further requested that the NIH extend this condemnation to experiments involving all biological organisms. 6
Although these notions have little scientific validity, they have a
strong emotional appeal because of our growing awareness that we
have misused many technologies. The term "telos" means " ultimate
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end or aim." The fossil record tells us that species arise, persist for a
time, and become extinct. Species have an ultimate fate, but it is we
who invent and ascribe purpose. Genetic and molecular experiments
show us that genes and chromosomes are in constant flux, that organisms change, and that species are man-made categories in the continuum of life. The principle of "species integrity," the notion that
there is a fixed, unchangeable, and inviolable genetic structure is Rifkin's invention. Yet we are especially vulnerable right now to critics of
science and technology. In our own country and throughout the
world, we are being forced to confront the consequences of our rapid
industrial and technological development. It is perhaps easiest and
even traditional to blame scientists, those who acquire the knowledge
that is used and misused. Our myths are full of fall guys. Eve took the
blame when Adam ate the fruit of the tree of knowledge. For the gift
of fire, Prometheus was chained to a rock and left for eagles to consume alive. Such myths are strong stuff: to be curious, to open Pandora's box, is to open a can of worms. Such myths make manifest our
deeply ambiguous feelings about the acquisition of knowledge. Ignorance, we say, is bliss. We would prefer to evade responsibility for
distinguishing between good and bad applications, the ethical and the
unethical uses of knowledge.
But the answer to arson is surely not to declare all use of fire
immoral. The answer is to define what arson is and to punish individuals who wantonly set fires, so that we might continue to use fire to
cook food and keep warm. And so it is with recombinant DNA and
gene transfer technology. Our distress over the disasters we have caused
with other technologies tempts us to think that if we did not have
certain kinds of knowledge, we would not be in the bind we are in.
Indeed, to use knowledge wisely, responsibly, and with compassion is
infinitely more difficult than to acquire it. But to declare the acquisition of knowledge outside the bounds of approved human activity, to
declare it immoral, is truly to discard both baby and bath water. It is to
discard the possibility of using biotechnology to help human beings
born with crippling genetic disorders. And perhaps of greater importance in the overall scheme of things, it is to discard the possibility
of using our knowledge of genes and organisms to achieve a better
balance between human beings and all the other creatures on our
populous planet.
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